Education
What Are Weight Loss Peptides?
Peptides are short chains of amino acids that serve as signaling molecules in the body. The weight loss peptides offered by telehealth providers are almost all GLP-1 receptor agonists (GLP-1 RAs) — drugs that mimic glucagon-like peptide-1, a hormone naturally released in the gut after eating.
When a GLP-1 agonist binds to its receptor, insulin secretion increases, digestion slows, and the brain receives stronger satiety signals. The result: most patients eat meaningfully less without feeling deprived — producing consistent, sustained weight loss over time.
Semaglutide (the active ingredient in Ozempic and Wegovy) targets only the GLP-1 receptor. Tirzepatide (Mounjaro, Zepbound) is a dual agonist — it hits both GLP-1 and GIP receptors — producing slightly greater average weight loss in head-to-head clinical trials, though typically at a somewhat higher cost.
All providers reviewed here offer compounded versions — containing identical active ingredients to brand-name drugs, prepared by licensed US compounding pharmacies at a fraction of the brand-name price.
⚖️
Average Weight Loss
Clinical trials show 10–22% body weight reduction over 12 months with tirzepatide; 10–15% with semaglutide.
💊
Same Active Ingredient
Compounded semaglutide and tirzepatide contain identical active ingredients to brand-name Ozempic, Wegovy, and Zepbound.
🏥
Prescription Required
All providers require a licensed clinician review before issuing any prescription. Non-prescription "peptides" are research-grade compounds unsafe for human use.
📉
Cost vs. Brand-Name
Brand-name GLP-1s cost ~$12,000/year without insurance. Compounded alternatives from these telehealth providers range from ~$1,750–$3,600/year.